Green D W, Bristow A S, Fisher M
Br J Anaesth. 1984 Sep;56(9):981-5. doi: 10.1093/bja/56.9.981.
The effectiveness of administration of glycopyrrolate 5 and 10 micrograms kg-1 and atropine 10 and 20 micrograms kg-1 i.v. immediately before the induction of anaesthesia, to prevent arrhythmia and bradycardia following repeated doses of suxamethonium in children, was studied. A control group was included for comparison with the lower dose range of glycopyrrolate and atropine. A frequency of bradycardia of 50% was noted in the control group, but this was not significantly different from the frequency with the active drugs. Bradycardia (defined as a decrease in heart rate to less than 50 beat min-1) was prevented when the larger dose of either active drug was used. It is recommended that either glycopyrrolate 10 micrograms kg-1 or atropine 20 micrograms kg-1 i.v. should immediately precede induction of anaesthesia, in children, if the repeated administration of suxamethonium is anticipated.
研究了在儿童麻醉诱导前即刻静脉注射5微克/千克和10微克/千克的格隆溴铵以及10微克/千克和20微克/千克的阿托品,以预防反复给予琥珀酰胆碱后出现心律失常和心动过缓的效果。设立了一个对照组,用于与较低剂量范围的格隆溴铵和阿托品进行比较。对照组的心动过缓发生率为50%,但这与使用活性药物时的发生率无显著差异。当使用较大剂量的任何一种活性药物时,心动过缓(定义为心率降至低于50次/分钟)得到了预防。建议如果预计要在儿童中反复给予琥珀酰胆碱,应在麻醉诱导前即刻静脉注射10微克/千克的格隆溴铵或20微克/千克的阿托品。